GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rapid Nutrition PLC (OTCPK:RPNRF) » Definitions » Debt-to-EBITDA

RPNRF (Rapid Nutrition) Debt-to-EBITDA : -0.08 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Rapid Nutrition Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Rapid Nutrition's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.12 Mil. Rapid Nutrition's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.01 Mil. Rapid Nutrition's annualized EBITDA for the quarter that ended in Dec. 2023 was $-1.55 Mil. Rapid Nutrition's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.08.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Rapid Nutrition's Debt-to-EBITDA or its related term are showing as below:

RPNRF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.11   Med: 1.6   Max: 4.83
Current: -0.1

During the past 10 years, the highest Debt-to-EBITDA Ratio of Rapid Nutrition was 4.83. The lowest was -0.11. And the median was 1.60.

RPNRF's Debt-to-EBITDA is ranked worse than
100% of 655 companies
in the Drug Manufacturers industry
Industry Median: 1.8 vs RPNRF: -0.10

Rapid Nutrition Debt-to-EBITDA Historical Data

The historical data trend for Rapid Nutrition's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Nutrition Debt-to-EBITDA Chart

Rapid Nutrition Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.97 1.91 4.83 -0.04 -0.11

Rapid Nutrition Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.30 0.26 -0.02 -0.12 -0.08

Competitive Comparison of Rapid Nutrition's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Rapid Nutrition's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rapid Nutrition's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rapid Nutrition's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Rapid Nutrition's Debt-to-EBITDA falls into.



Rapid Nutrition Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Rapid Nutrition's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.12 + 0.01) / -1.208
=-0.11

Rapid Nutrition's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.12 + 0.01) / -1.548
=-0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Rapid Nutrition  (OTCPK:RPNRF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Rapid Nutrition Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Rapid Nutrition's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Rapid Nutrition Business Description

Traded in Other Exchanges
Address
124 City Road, London, GBR, EC1V 2NX
Rapid Nutrition PLC is a natural healthcare company. The company is engaged in development and distribution of premium, science based health and wellness brands. The company's Flagship brands are, 1) SystemLS; 2) Leisa's Secret and 3) The Plant-Based Bundle.